Diamond-Blackfan Anemia

This is a rare type of anemia that starts in babies. It's caused by a problem with the bone marrow, the part of the body that makes blood cells. People with this condition have fewer red blood cells than normal, which can make them tired and weak. It's a serious condition that needs careful medical care.

Condition

What people with Diamond-Blackfan Anemia report

Every report comes from a Lived member, sent anonymously.

Have you had Blood Transfusion for Diamond-Blackfan Anemia?

NameHow it went

About Diamond-Blackfan Anemia

What It Is

Diamond-Blackfan anemia (DBA) is a rare inherited condition in which the bone marrow does not make enough red blood cells, the cells that carry oxygen around the body. Other blood cells are usually made in near-normal numbers, which sets it apart from conditions where the whole marrow fails. The resulting anemia causes paleness, tiredness and weakness, and in most people it becomes noticeable in the first year of life, often around 3 months of age. DBA is more than a blood problem. More than half of people with it have a physical difference present from birth, such as a cleft lip or palate, thumb or hand differences, or heart, kidney or eye abnormalities. It also carries a higher lifetime risk of certain cancers. Because the features vary so much, even within one family, specialists now often use the term DBA syndrome. Some people are diagnosed only in adulthood, and a few carry the gene change without ever developing anemia.

Causes & Risk Factors

DBA is caused by a change in a gene, not by anything a parent did during pregnancy or anything that happens after birth. In most cases the affected gene carries instructions for part of the ribosome, the machinery cells use to build proteins. Red blood cell production seems especially sensitive to this shortfall, so early red cells die off in the marrow before they mature. In roughly 20 to 30 percent of people, no genetic cause can yet be found. Most forms follow a dominant pattern, meaning one altered copy of the gene is enough to cause the condition, and a parent with it has a 50 percent chance of passing it to each child. About two-thirds of cases are new in the family, while about one-third are inherited. Relatives with the same gene change can be affected very differently, from needing regular transfusions to having no symptoms at all.

How It's Diagnosed

DBA is usually suspected when a baby or young child has anemia with very few reticulocytes (young red blood cells), which shows the marrow is not keeping up. The red cells are often larger than normal. Blood tests check the complete blood count, and a bone marrow sample typically shows that the cells that should become red blood cells are missing or scarce while the rest of the marrow looks normal. Genetic testing is recommended for everyone with suspected DBA. Finding a disease-causing change in a known DBA gene confirms the diagnosis, and once one is found, testing relatives can show who else carries it. Because a gene change cannot be found in everyone, the diagnosis can also rest on the typical blood and marrow findings once other causes have been ruled out. A blood test called erythrocyte adenosine deaminase (eADA) is often raised in DBA and helps support the diagnosis; it needs to be drawn before a first transfusion, since donor blood changes the result. The most important look-alike in young children is transient erythroblastopenia of childhood, a temporary pause in red cell production that recovers on its own and does not need long-term treatment. Some viral infections, especially parvovirus B19, can also briefly stop red cell production. A full assessment also includes a careful physical examination and imaging to look for birth differences, since some are not obvious at first.

Treatment Options

Treatment aims to keep hemoglobin, the oxygen-carrying protein in red blood cells, high enough for normal growth, development and energy. Current expert guidance recommends keeping it at about 9 to 10 grams per deciliter or higher, measured just before each transfusion, at every age. There are three main approaches, and many people move between them over time. Folate and other vitamins do not correct this kind of anemia. Regular red blood cell transfusions are often the first treatment, especially for infants. Many people need them about every three weeks. Their main drawback is iron: each transfusion adds iron the body cannot get rid of, and in DBA it builds up quickly in the liver, heart and hormone-producing glands. Iron chelation medicines bind the extra iron so it can leave the body. Deferoxamine is given as a slow infusion under the skin, usually overnight, and deferasirox is taken by mouth; many people need both. MRI scans of the liver and heart measure how much iron has built up and guide the dose, ideally starting by age 5 and repeating yearly. Corticosteroids (prednisone or prednisolone) can switch red cell production back on in many people. They are usually started after a child's first birthday. About 60 to 80 percent respond at first, but many later lose the response or cannot stay on a low enough dose, and about 30 to 40 percent continue on steroids long term. The aim is the smallest dose that keeps hemoglobin up, because long-term steroids can slow a child's growth and cause the usual steroid side effects, and the body's own stress-hormone production needs monitoring. A stem cell transplant (bone marrow transplant) replaces the faulty marrow and is the only treatment that cures the anemia. It is mainly recommended for children who still need transfusions, ideally before age 10, with a well-matched brother, sister or unrelated donor. Survival with a matched donor is now around 90 percent in large European studies, but transplant carries serious risks, including graft-versus-host disease (donor immune cells attacking the body) and future infertility, and it does not remove the higher cancer risk. A sibling donor is tested first to make sure they do not carry the same gene change. Adults are generally not offered transplant for transfusion needs alone. About 1 in 5 people eventually stop needing any treatment for anemia, often during childhood, though the anemia can return. Newer approaches, including the amino acid L-leucine, are being studied but are not yet standard care.

What to Expect

DBA is life-long, and the course differs widely from person to person. Some people stay on a low steroid dose for years, some need regular transfusions and chelation as part of their routine, and some reach a point where they need no treatment at all. Transfusion-dependent life usually means a day in clinic every few weeks plus daily or nightly chelation, which can affect school, work and family plans. Short stature is common, partly from the condition and partly from steroids, anemia and iron, so growth and puberty are followed closely, and some children take a planned break from steroids to help growth. Care is ideally coordinated by a hematologist with DBA experience, together with other specialists as needed. Follow-up continues even when treatment is not needed, because the cancer risk does not go away. This includes a complete blood count every 3 to 4 months to watch for changes that could signal myelodysplastic syndrome (MDS, a disorder of faulty blood cell production) or acute myeloid leukemia (AML), and colonoscopy to screen for colorectal cancer from age 20, repeated every 5 years if normal. People who receive transfusions are vaccinated against hepatitis B and checked regularly for blood-borne infections. As children with DBA reach adulthood, moving to adult care, genetic counseling for family planning and specialist care during pregnancy become important. Pregnancy in DBA is treated as high risk.

When to Seek Help

See a doctor if a baby or child seems persistently pale, or unusually tired, especially when there is a known family history of DBA or a birth difference such as a thumb or palate abnormality. Relatives of someone with a known DBA gene change can ask about testing even if they feel well. For someone already diagnosed, contact the care team promptly if paleness, tiredness or breathlessness gets noticeably worse between scheduled checks or transfusions, if a fever or infection develops while on steroids, or if bone or joint pain or swelling persists, since this should be checked with imaging.

Questions to Ask Your Doctor

  1. 1.Has genetic testing found the cause, and which family members should be tested?
  2. 2.Is a trial of steroids, ongoing transfusions or a stem cell transplant the best fit at this stage, and what would make us change course?
  3. 3.How will iron build-up be measured, and what does the chelation plan involve day to day?
  4. 4.Which cancer screening and blood count checks do we need, and how often?
  5. 5.Is there a DBA specialist center or registry we should be connected with?

Last reviewed • Oct 2026

Educational content, not medical advice.